About: maprx

Recent Posts by maprx

Briefing Memo: “Protected Classes”

The Medicare Access for Patients Rx (MAPRx) Coalition, comprised of more than fifty-five beneficiary advocacy organizations, urges the Centers for Medicare and Medicaid Services (CMS) to reverse its proposed policy changes to the Medicare Part D six “protected classes.”  Proposed changes will limit access to medications under the Part D benefit for...

Read more

Medicare Prescription Drug Open Enrollment Questions and Answers

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2013 – December 7, 2013. Certain people with Medicare can also change plans at other times (see question #13). Plans are making changes to benefits and costs, and there are also new plans in many areas of the country. In 2014,...
Read more

REVISING SPECIALTY TIERS: PROTECTING MEDICARE PART D BENEFICIARIES FROM BURDENSOME COST SHIFTING

>> Download the Report Here [PDF]

THE MAPRx COALITION RELEASES REPORT ON WAYS TO IMPROVE PATIENT PRESCRIPTION DRUG ACCESS, AS LAWMAKERS TAKE STEPS TO TACKLE ISSUE OF SPECIALTY TIERS IN MEDICARE PART D

WASHINGTON, D.C., July 25, 2013 – The MAPRx Coalition (MAPRx) today released, “Revising Specialty Tiers: Protecting Medicare Part D Beneficiaries from Burdensome...
Read more

April 2013 Letter to Congress

Dear Members of Congress: Medicare Access for Patients RX or MAPRx brings together national beneficiary, patient advocacy, family caregiver, and health professional organizations committed to ensuring and improving access to prescription medications and safeguarding the well-being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D).  On behalf of millions of...
Read more

MAPRx Letter to Acting CMS Administrator Marilyn Tavenner

Ms. Marilyn Tavenner Acting Administrator Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244 Re: Draft 2014 Call Letter for the Medicare Advantage (MA) and Prescription Drug Programs Dear Acting Administrator Tavenner: On behalf of millions of Medicare beneficiaries with chronic diseases and conditions who rely on Medicare Part D for essential medications, MAPRx appreciates the opportunity...
Read more

Letter to Congress Re: Drug Benefit Design

Dear Member of Congress – MAPRx brings together beneficiary, patient advocacy, family caregiver and health professional organizations committed to improving access to prescription medications and safeguarding the well being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D). On behalf of millions of Medicare beneficiaries with chronic conditions who rely...
Read more

October 2012 Briefing on Capitol Hill

    Staff from 50 Congressional offices listened to Juliette Cubanski from the Kaiser Family Foundation; Bonnie Washington from Avalere; and, Leslie Fried present “Medicare Part D: Building on its Successes and Learning from its Limitations.”

    Juliette’s presentation is reproduced below:


    MAPRx Comments on Draft 2013 Medicare Call Letter

    March 2, 2012 Marilyn Tavenner Acting Administrator Centers for Medicare and Medicaid Services 7500 Security Blvd. Baltimore, MD 21244 Dear Ms. Tavenner: MAPRx brings together beneficiary, patient advocacy, family caregiver and health professional organizations committed to improving access to prescription medications and safeguarding the well-being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D). On...
    Read more

    Letter to Congress on Proposed Part D Changes

    capitoldomeDear Member of Congress – MAPRx brings together beneficiary, patient advocacy, family caregiver and health professional organizations committed to improving access to prescription medications and safeguarding the well- being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D). On behalf of millions...
    Read more

    Recent Comments by maprx

      No comments by maprx yet.